首页 | 本学科首页   官方微博 | 高级检索  
检索        

化瘀明目饮对糖尿病患者白内障术后黄斑区的保护作用
引用本文:钱锦,朱炜敏,肖燕倩,忽俊,陆豪,唐建明.化瘀明目饮对糖尿病患者白内障术后黄斑区的保护作用[J].眼科新进展,2016,0(2):165-168.
作者姓名:钱锦  朱炜敏  肖燕倩  忽俊  陆豪  唐建明
作者单位:201900 上海市,上海市宝山区中西医结合医院眼科
基金项目:上海市卫生局青年课题基金资助(20124Y026),上海市宝山区科学技术委员会课题基金资助(编号:12-E-19)Shanghai Municipal Health Bureau Youth Project(20124Y026),Shanghai Baoshan District Science and Technology Commission Project(12-E-19)
摘    要:目的 探讨口服化瘀明目饮对糖尿病患者白内障超声乳化吸出联合人工晶状体(intraocularlens,IOL)植入术后黄斑区的保护作用。方法 将我院眼科2013年1月至2015年1月行白内障手术合并糖尿病患者92例(100眼)随机分为治疗组和对照组。对照组50例(50眼)术后应用妥布霉素地塞米松眼液治疗,治疗组42例(50眼)在对照组治疗方法的基础上术后化瘀明目饮口服4周。两组分别于术前及术后1周、1个月、3个月对患者进行眼部常规检查,包括最佳矫正视力(bestcorrectedvisualacuity,BCVA)、眼压、眼底检查,并利用光学相干断层扫描(opticalcoherencetomography,OCT)测量黄斑中心凹视网膜厚度和黄斑区总容积。结果 两组白内障患者术后视力均较术前显著提高,差异均有统计学意义(t=2.853、2.610,均为P<0.01)。治疗组术后BCVA的恢复情况显著优于对照组(Z=-2.074、-2.587、-2.264,均为P<0.05)。两组术后1周、1个月、3个月黄斑中心凹视网膜厚度和黄斑总容积均较术前增加(均为P<0.05),治疗组术后1周、1个月黄斑中心凹视网膜厚度低于对照组,差异均有统计学意义(t=-2.343,P<0.05;t=-2.992,P<0.01),治疗组术后3个月黄斑中心凹视网膜厚度较对照组降低,差异无统计学意义(t=-1.739,P>0.05)。治疗组术后1个月有3眼(6%)出现黄斑水肿,对照组术后1个月有9眼(18%)出现黄斑水肿,两组黄斑水肿的发生率差异有统计学意义(P<0.05)。结论 化瘀明目饮可防止糖尿病患者白内障术后黄斑中心凹视网膜厚度增加,有效降低术后黄斑水肿的发生率。

关 键 词:糖尿病  白内障超声乳化术  黄斑水肿  光学相干断层扫描

Protective effects of huyumingmu decoction on macular area after phacoemulsification in diabetic patients
QIAN Jin,ZHU Wei-Min,XIAO Yan-Qian,HU Jun,LU Hao,TANG Jian-Ming.Protective effects of huyumingmu decoction on macular area after phacoemulsification in diabetic patients[J].Recent Advances in Ophthalmology,2016,0(2):165-168.
Authors:QIAN Jin  ZHU Wei-Min  XIAO Yan-Qian  HU Jun  LU Hao  TANG Jian-Ming
Institution:Department of Ophthalmology , Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine , Shanghai 201900 , China
Abstract:Objective To investigate the protective effects of huayunungmu decoction on macular area after phacoemulsification with IOL implantation in diabetic patients. Methods Ninety-two diabetic patients with cataract ( 100 eyes) treated with phacoemulsification in our hospital from January 2013 to January 2015 were randomly divided into the treatment group and the control group. The control group ( 50 cases ,50 eyes) was treated with tobramycin and dexamethasone eye drops after operation; On this basis .the treatment group (42 cases ,50 eyes) used oral Huayunungmu decoction at I day after operation for 4 weeks. The routine ophthalmic exanunation including best corrected visual aaity( BCVA) .intraocular pressure and fundus examination were performed . and optical coherence tomography ( OCT) was used to detect the central foveal thickness and total volume of the macula before operation and at I week,l month,3 months after operation. Results The postoperative BCVA in the two groups was improved sigruficantly ( t = 2. 853 ,2. 610 . all P < 0. 01 ) . BCVA improvement at postoperative I week.l month,3 months in the treatment group was better than that in the control group ( z = - 2. 074 , - 2. 587 , - 2. 264 . all P < 0. 05 ) . The central foveal retinal thickness at postoperative I week. I months in the treatment group was significantly lower than that in the control group ( t = - 2. 343 ,P < 0. 05 ; t = - 2. 992 ,P < 0. 01 ) . The central foveal retinal thickness at postoperative 3 months in the treatment group was lower than that in the control group ,but the difference was not significant ( t = - 1. 739 .P > 0. 05 ) . The incidence rate of macular edema at postoperative I months in the treatment group was 6. 00% .which was markedly lower than 18. 00% in the control group (P < 0. 05 ) . Conclusion Huayumingmu decoction can prevent the increase of postoperative central foveal thickness and effectively reduce the incidence of macular edema after phacoemulsification in diabetic patients.
Keywords:diabetes  phacoemulsification  macular edema  optical coherence tomography
本文献已被 万方数据 等数据库收录!
点击此处可从《眼科新进展》浏览原始摘要信息
点击此处可从《眼科新进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号